Assay Development Research Scientist I

Fulgent Genetics; California, El Monte (MO, CA); On-site; USD 88,000 - 108,000; Full time

Job summary

An innovative firm in the biotech sector is seeking an Assay Development Research Scientist 1 to lead the development of high-sensitivity genetic tests using Next-Generation Sequencing (NGS). This role emphasizes collaboration and innovation, requiring expertise in molecular biology and a passion for advancing patient care. You will be instrumental in designing automated tests, troubleshooting laboratory processes, and ensuring quality control. Join a team dedicated to transforming healthcare through cutting-edge genomic solutions and make a significant impact in the field of precision medicine.

Qualifications

• PhD or Master’s in a related field with significant experience in NGS.
• Strong understanding of human genetics and laboratory procedures.

Responsibilities

• Develop high-sensitivity tests for NGS and optimize genetic assays.
• Collaborate across teams to develop and maintain assays.

Skills

Next-Generation Sequencing (NGS)

DNA/RNA library preparation

Genotyping

Bioinformatics

Project Management

Education

PhD in Molecular Biology

Master’s in Molecular Biology

Job description

Job Details

Level: Experienced

Job Location: Fulgent 4399 El Monte - El Monte, CA

Position Type: Full Time

Education Level: Graduate Degree

Salary Range: $88,000.00 - $107,500.00 per year

Job Category: Biotech

Description

ABOUT FULGENT: Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform. We focus on transforming patient care in oncology, pathology, infectious and rare diseases, and reproductive health, offering effective and flexible testing options with top-tier service. Additionally, we are developing drug candidates for cancer treatment using innovative nanoencapsulation and targeted therapy platforms, aiming to become a fully integrated precision medicine company.

SUMMARY OF POSITION: The Assay Development Research Scientist 1 position is suited for candidates experienced in developing high-sensitivity, scalable tests, particularly with Next-Generation Sequencing (NGS). Responsibilities include designing and developing automated, high-throughput genetic tests from concept to commercial launch, within a collaborative environment emphasizing cross-functional projects. The role involves assessing and integrating new technologies, troubleshooting, and maintaining assays.

Key Job Elements

• Develop high-sensitivity tests for NGS.
• Develop, test, and evaluate NGS technologies.
• Troubleshoot laboratory preparation and Illumina sequencing instruments.
• Design and analyze experiments independently.
• Optimize genetic assays and communicate results clearly.
• Conduct quality control of algorithms for panels.
• Ensure attention to detail and organization.
• Participate in designing and launching new tests.
• Collaborate across teams to develop and maintain assays.

Qualifications

Knowledge / Experience:

• PhD or Master’s in Molecular Biology, Biochemistry, Genetics, or related field; >5 years for Master’s, >3 years for PhD preferred.
• Experience with DNA/RNA library prep, Target amplification, NGS.
• Knowledge of human genetics, NGS, genotyping.
• Experience with CLIA/CAP labs and genetic testing companies preferred.
• Basic bioinformatics understanding.
• Knowledge of HIPAA, SOPs, and safety procedures.
• Ability to correlate NGS data with lab procedures.
• Attention to detail, accuracy, and ability to work independently and collaboratively.
• Strong interpersonal skills and project management.

Supervisory Responsibilities: None

Reports To: Director of R&D

Environment

Fulgent Therapeutics LLC is an Equal Employment Opportunity Employer. Reasonable accommodations are provided for qualified individuals with disabilities. For California residents, see our CCPA Privacy Notice.

Note: We do not accept unsolicited resumes from search firms without a contract or approval. Resumes submitted without agreement will not be compensated and will be property of Fulgent.